Rie Sugimoto

11PUBLICATIONS
24CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutrigenomics and personalised nutritionCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 05, 2026
Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis.

Lingaku Lee, Yuichi Tachibana, Susumu Matsuo

|Sep 26, 2025
Advances in Systemic Therapy for Hepatocellular Carcinoma and Future Prospects.

Rie Sugimoto, Miho Kurokawa, Yuki Tanaka

|Aug 09, 2025
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.

Eiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi

|May 31, 2025
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria.

Takashi Niizeki, Seiichi Mawatari, Michihiko Shibata

|Feb 03, 2025
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals.

Eiichi Ogawa, Akira Kawano, Motoyuki Kohjima

|Sep 02, 2023
Zinc Deficiency as a General Feature of Cancer: a Review of the Literature.

Rie Sugimoto, Lingaku Lee, Yuki Tanaka

Pageof 2

Frequent Collaborators

3 joint publications

Eiichi Ogawa

3 joint publications

Masatake Tanaka

2 joint publications

Lingaku Lee

2 joint publications

Terumasa Hisano